Nijhawan Amends Edesa Biotech Stake, Signals Continued Insider Confidence

TL;DR

**Insider Dr. Pardeep Nijhawan is still a major holder in Edesa Biotech, signaling strong conviction.**

AI Summary

Dr. Pardeep Nijhawan, through Pardeep Nijhawan Medicine Professional Corp and other entities, has filed an Amendment No. 6 to his Schedule 13D, indicating a continued significant ownership stake in Edesa Biotech, Inc. This filing, dated January 16, 2024, updates previous disclosures regarding his beneficial ownership of Common Shares, no par value per share, of Edesa Biotech. This matters to investors because Dr. Nijhawan is a key insider, and his substantial, ongoing stake suggests a strong belief in the company's future, potentially signaling stability or future strategic moves.

Why It Matters

This filing shows that a key insider, Dr. Pardeep Nijhawan, maintains a significant ownership position in Edesa Biotech, which can be interpreted as a vote of confidence in the company's long-term prospects.

Risk Assessment

Risk Level: low — This filing is an amendment to an existing Schedule 13D, indicating a stable, ongoing insider ownership rather than a new, volatile event.

Analyst Insight

A smart investor would note the continued insider ownership by Dr. Pardeep Nijhawan as a potential positive signal, but should conduct further due diligence on Edesa Biotech's financials and pipeline before making any investment decisions.

Key Players & Entities

• Dr. Pardeep Nijhawan (person) — Reporting Person and significant beneficial owner of Edesa Biotech, Inc.
• Edesa Biotech, Inc. (company) — Subject Company whose securities are being reported.
• Pardeep Nijhawan Medicine Professional Corp (company) — Filing entity associated with Dr. Pardeep Nijhawan.
• 1968160 ONTARIO INC. (company) — Group Member associated with the filing.
• DIGESTIVE HEALTH CLINIC INC. (company) — Group Member associated with the filing.
• NEW NIJHAWAN FAMILY TRUST 2015 (company) — Group Member associated with the filing.

Forward-Looking Statements

• Dr. Pardeep Nijhawan will likely maintain a significant ownership stake in Edesa Biotech, Inc. for the foreseeable future. (Dr. Pardeep Nijhawan) — high confidence, target: 2025-01-16
• Edesa Biotech, Inc. may experience increased investor confidence due to the continued insider holding by Dr. Nijhawan. (Edesa Biotech, Inc.) — medium confidence, target: 2024-07-16

FAQ

Filing Documents

• edsa_sc13da.htm (SC 13D/A) — 121KB
• 0001654954-24-000633.txt ( ) — 123KB

Source and Amount of Funds or Other Consideration

Item 3. Source and Amount of Funds or Other Consideration.

is hereby supplemented as follows

Item 3 is hereby supplemented as follows: On January 8, 2024, the Issuer granted Dr. Pardeep Nijhawan 2,908 restricted stock units, which vested in full upon grant.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer. (a)-(b) Number of Common Shares beneficially owned: Pardeep Nijhawan Medicine Professional Corporation (1) 353,007 shares The Digestive Health Clinic Inc. 32,013 shares 1968160 Ontario Inc. 53,104 shares The New Nijhawan Family Trust 2015 (2) 48,914 shares Pardeep Nijhawan (3) 630,012 shares SCHEDULE 13D (1) Includes 16,305 Common Shares underlying vested warrants that are deemed outstanding with respect to this Reporting Person. (2) Includes 16,305 Common Shares underlying vested warrants that are deemed outstanding with respect to this Reporting Person. (3) Includes 84,973 Common Shares, 17,094 Common Shares underlying vested restricted stock units and 40,907 Common Shares underlying vested share options held directly by Dr. Pardeep Nijhawan, 336,702 Common Shares and an additional 16,305 Common Shares underlying vested warrants that are deemed outstanding held by Pardeep Nijhawan Medicine Professional Corporation, 32,013 Common Shares held by The Digestive Health Clinic Inc., 53,104 Common Shares held by 1968160 Ontario Inc., and 32,609 Common Shares and an additional 16,305 Common Shares underlying vested warrants that are deemed outstanding held by The New Nijhawan Family Trust 2015. Percent of class: Pardeep Nijhawan Medicine Professional Corporation (1) 11.1 % The Digestive Health Clinic Inc. (2) 1.0 % 1968160 Ontario Inc. (2) 1.7 % The New Nijhawan Family Trust 2015 (3) 1.5 % Pardeep Nijhawan (4) 19.3 % (1) Based on a total of 3,170,776 Common Shares of the Company outstanding as of January 11, 2024 and an additional 16,305 Common Shares underlying vested warrants that are deemed outstanding with respect to this Reporting Person. (2) Based on a total of 3,170,776 Common Shares of the Company outstanding as of January 11, 2024. (3) Based on a total of 3,170,776 Common Shares of the Company outstanding as of January 11, 2024 and an additional 16,305 Common Shares underlying

View Full Filing

View this SC 13D/A filing on SEC EDGAR